AQST
Aquestive Therapeutics Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 2/10
- Value↓ 0/10
AQST Growth
- Revenue Y/Y↓ -22.61%
- EPS Y/Y↓ -52.94%
- FCF Y/Y↓ -47.54%
AQST Profitability
- Gross margin ↑ 58.30%
- EPS margin↓ -188.10%
- ROIC 5Y↓ -20.80%
AQST Risk
- Debt / Equity↑ 999.0
- Debt / FCF↓ 0.2
- Interest coverage↓ -3.9
Aquestive Therapeutics stock volatility is in-line with the overall market. We give it a Poor risk rating.